Natera Inc (NTRA)

123.54 -2.14  -1.70% NASDAQ Sep 23, 16:00 123.50 -0.04  -0.03% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All NTRA News

News

View All Events

Events

Date Type Description
11/05/2021 Earnings Results Q3 2021 Earnings Results
11/05/2021 16:30 EST Earnings Calls Q3 2021 Earnings Call
08/05/2021 Earnings Results Q2 2021 Earnings Results
08/05/2021 16:30 EST Earnings Calls Q2 2021 Earnings Call
05/25/2021 14:30 EST AGM 2020 Annual General Meeting
05/06/2021 Earnings Results Q1 2021 Earnings Results
05/06/2021 16:30 EST Earnings Calls Q1 2021 Earnings Call
02/25/2021 Earnings Results Q4 2020 Earnings Results
02/25/2021 16:30 EST Earnings Calls Q4 2020 Earnings Call
11/05/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Natera Inc is operative in the healthcare field in the United States. Its core business is to offer invasive and other means of diagnosing the genetic features of a fetus. Natera's array of diagnostic services include Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, Anora Products of Conception (POC) test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing (PAT), to determine paternity by studying the fragments of fetal deoxyribonucleic acid (DNA) in a pregnant mother's blood and a blood sample from the alleged father. The Company acquires its revenue by billing an insurance carrier, a clinic, or a patient for the test upon delivery of the test result.
  • URL: https://www.natera.com
  • Investor Relations URL: https://investor.natera.com
  • HQ State/Province: Texas
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Nov. 05, 2021
  • Last Earnings Release: Aug. 05, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
ASYMX Alger Weatherbie Specialized Growth Y 5.86%
GNOM Global X Genomics & Biotechnology ETF 4.42%
PTH Invesco DWA Healthcare Momentum ETF 3.81%
AOFCX Alger Small Cap Focus C 3.28%
WGFCX Wells Fargo Growth C 2.69%
BBH VanEck Biotech ETF 2.34%
LADQX Lord Abbett Developing Growth R2 1.81%
ASG Liberty All-Star Growth 1.74%
ASPYX Alger Spectra Y 1.28%
FKBSX Federated Hermes Kaufmann Small Cap B 1.17%
XBI SPDR® S&P Biotech ETF 0.77%
SCHA Schwab US Small-Cap ETF™ 0.26%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.